AAAAAA
Results: 26-50/87
Authors:
SORBARA LR
MALDARELLI F
CHAMOUN G
SCHILLING B
CHOKEKIJCAHI S
STAUDT L
MITSUYA H
SIMPSON IA
ZEICHNER SL
Citation: Lr. Sorbara et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF H9 CELLS INDUCES INCREASED GLUCOSE-TRANSPORTER EXPRESSION, Journal of virology, 70(10), 1996, pp. 7275-7279
Authors:
DRISCOLL JS
SIDDIQUI MA
FORD H
KELLEY JA
ROTH JS
MITSUYA H
TANAKA M
MARQUEZ VE
Citation: Js. Driscoll et al., LIPOPHILIC, ACID-STABLE, ADENOSINE DEAMINASE-ACTIVATED ANTI-HIV PRODRUGS FOR CENTRAL-NERVOUS-SYSTEM DELIVERY .3. 6-AMINO PRODRUGS OF 2'-BETA-FLUORO-2',3'-DIDEOXYINOSINE, Journal of medicinal chemistry, 39(8), 1996, pp. 1619-1625
Authors:
WINTER H
MAEDA Y
MITSUYA H
ZEMLICKA J
Citation: H. Winter et al., PHOSPHODIESTER AMIDATES OF ALLENIC NUCLEOSIDE ANALOGS - ANTI-HIV ACTIVITY AND POSSIBLE MECHANISM OF ACTION, Journal of medicinal chemistry, 39(17), 1996, pp. 3300-3306
Authors:
SATO H
KIKUCHI A
NAKAI J
MITSUYA H
SHIMATSU T
TAKAHASHI M
Citation: H. Sato et al., EFFECTS OF GRAIN-SIZE AND INTERGRANULAR COUPLING ON RECORDING CHARACTERISTICS IN COCRTA MEDIA, IEEE transactions on magnetics, 32(5), 1996, pp. 3596-3598
Authors:
MITSUYA H
Citation: H. Mitsuya, RITONAVIR - A VIEWPOINT, Drugs, 52(4), 1996, pp. 547-548
Authors:
UENO T
MITSUYA H
Citation: T. Ueno et H. Mitsuya, CURRENT STATUS OF THE DEVELOPMENT OF HIV PROTEASE INHIBITORS AND THEIR CLINICAL POTENTIAL, CLINICAL IMMUNOTHERAPEUTICS, 4(6), 1995, pp. 451-461
Authors:
ARNOLD E
DAS K
DING JP
HSIOU Y
TANTILLO C
ROY BM
YADAV P
ZHANG WY
LENTZ K
CLARK AD
BOYER PL
HUGHES SH
MITSUYA H
MELLORS J
KLEIM JP
ROSNER M
MOEREELS HR
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7
Authors:
GULNIK SV
SUVOROV LI
LIU B
YU B
ANDERSON B
MITSUYA H
VAILLANCOURT M
SWANSTROM R
ERICKSON JW
Citation: Sv. Gulnik et al., KINETIC CHARACTERIZATION OF HIV-1 PROTEASE MUTANTS SELECTED UNDER IN-VITRO DRUG PRESSURE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 59-59
Authors:
BALDWIN ET
BHAT TN
GULNIK S
LIU BS
TOPOL IA
KISO Y
MIMOTO T
MITSUYA H
ERICKSON JW
Citation: Et. Baldwin et al., STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE, Structure, 3(6), 1995, pp. 581-590
Authors:
SCHILLING B
QUAN E
CHOKEKIJCHAI S
MITSUYA H
STAUDT L
ZEICHNER SL
Citation: B. Schilling et al., ACUTE HIV-1 INFECTION OF H-9 CELLS LEADS TO DISTINCT TEMPORAL PATTERNS OF CELLULAR GENE-EXPRESSION, AIDS research and human retroviruses, 11, 1995, pp. 114-114
Authors:
GAO WY
JOHNS DG
AHLUWALIA G
MITSUYA H
Citation: Wy. Gao et al., ENHANCEMENT OF THE ANTI-HIV-1 ACTIVITY OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE (D4T) BY THE THYMIDYLATE SYNTHETASE INHIBITOR FUDR - AN ANTI-HIV STRATEGY WITH A HOST-CELL TARGET, AIDS research and human retroviruses, 11, 1995, pp. 161-161
HIV-1 PROTEASE FUNCTION PRIOR TO VIRAL BUDDING IS ESSENTIAL FOR THE PRODUCTION OF INFECTIOUS VIRIONS
Authors:
HUMPHREY RW
SAVILLE MW
MITSUYA H
YARCHOAN R
Citation: Rw. Humphrey et al., HIV-1 PROTEASE FUNCTION PRIOR TO VIRAL BUDDING IS ESSENTIAL FOR THE PRODUCTION OF INFECTIOUS VIRIONS, AIDS research and human retroviruses, 11, 1995, pp. 162-162
Authors:
SOGOCIO KM
ANDERSON B
KAVLICK M
SAVILLE W
WAINBERG MA
CHERRINGTON JM
MITSUYA H
YARCHOAN R
Citation: Km. Sogocio et al., HIV-1 DEVELOPS REDUCED SENSITIVITY TO 9-(2-PHOSPHONYLMETHOXYETHYL) ADENINE (PMEA) IN-VITRO THROUGH ACQUISITION OF K65R, AIDS research and human retroviruses, 11, 1995, pp. 164-164
Authors:
SHIRASAKA T
CHOKEKIJCHAI S
GOSSELIN G
IMBACH JL
MITSUYA H
Citation: T. Shirasaka et al., DIVERGENT ANTI-HIV ACTIVITY OF DIDEOXY-NUCLEOSIDES IN RESTING AND ACTIVATED, Journal of cellular biochemistry, 1995, pp. 198-198
Authors:
KAVLICK MF
SHIRASAKA T
KOJIMA E
PLUDA JM
HUI F
YARCHOAN R
MITSUYA H
Citation: Mf. Kavlick et al., GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HIV-1 ISOLATED FROM PATIENTS RECEIVING (-)-2',3'-DIDEOXY-3'-THIACYTIDINE, Antiviral research, 28(2), 1995, pp. 133-146
Authors:
CHOKEKIJCHAI S
SHIRASAKA T
WEINSTEIN JN
MITSUYA H
Citation: S. Chokekijchai et al., IN-VITRO ANTI-HIV-1 ACTIVITY OF HIV PROTEASE INHIBITOR KNI-272 IN RESTING AND ACTIVATED CELLS - IMPLICATIONS FOR ITS COMBINED USE WITH AZT OR DDI, Antiviral research, 28(1), 1995, pp. 25-38
Authors:
HAWKINS ME
MITSUYA H
MCCULLY CM
GODWIN KS
MURAKAMI K
POPLACK DG
BALIS FM
Citation: Me. Hawkins et al., PHARMACOKINETICS OF DIDEOXYPURINE NUCLEOSIDE ANALOGS IN PLASMA AND CEREBROSPINAL-FLUID OF RHESUS-MONKEYS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1259-1264
Authors:
SHIRASAKA T
CHOKEKIJCHAI S
YAMADA A
GOSSELIN G
IMBACH JL
MITSUYA H
Citation: T. Shirasaka et al., COMPARATIVE-ANALYSIS OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF DIDEOXYNUCLEOSIDE ANALOGS IN RESTING AND ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2555-2559
Authors:
CHOKEKIJCHAI S
KOJIMA E
ANDERSON S
NOMIZU M
TANAKA M
MACHIDA M
DATE T
TOYOTA K
ISHIDA S
WATANABE K
YOSHIOKA H
ROLLER PP
MURAKAMI K
MITSUYA H
Citation: S. Chokekijchai et al., NP-06 - A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS POLYPEPTIDE PRODUCED BY A STREPTOMYCES SPECIES, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2345-2347
Authors:
SHIRASAKA T
KAVLICK MF
UENO T
GAO WY
KOJIMA E
ALCAIDE ML
CHOKEKIJCHAI S
ROY BM
ARNOLD E
YARCHOAN R
MITSUYA H
Citation: T. Shirasaka et al., EMERGENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH RESISTANCE TO MULTIPLE DIDEOXYNUCLEOSIDES IN PATIENTS RECEIVING THERAPY WITHDIDEOXYNUCLEOSIDES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(6), 1995, pp. 2398-2402
Authors:
GAO WY
JOHNS DG
CHOKEKIJCHAI S
MITSUYA H
Citation: Wy. Gao et al., DISPARATE ACTIONS OF HYDROXYUREA IN POTENTIATION OF PURINE AND PYRIMIDINE 2',3'-DIDEOXYNUCLEOSIDE ACTIVITIES AGAINST REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8333-8337
Authors:
HUSSON RN
LAN Y
KOJIMA E
VENZON D
MITSUYA H
MCINTOSH K
Citation: Rn. Husson et al., VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - AUTOLOGOUS NEUTRALIZING ANTIBODY, VIRUS LOAD, AND VIRUS PHENOTYPE, The Journal of pediatrics, 126(6), 1995, pp. 865-871
Authors:
JONES BCNM
SILVERTON JV
SIMONS C
MEGATI S
NISHIMURA H
MAEDA Y
MITSUYA H
ZEMLICKA J
Citation: Bcnm. Jones et al., SYNTHESIS, ABSOLUTE-CONFIGURATION, AND ENANTIOSELECTIVITY OF ANTIRETROVIRAL EFFECT OF (R)-(-)-CYTALLENE AND (S)-(-CYTALLENE - LIPASE-CATALYZED ENANTIOSELECTIVE ACYLATIONS OF (+())-)-N-4-ACYLCYTALLENES/, Journal of medicinal chemistry, 38(8), 1995, pp. 1397-1405
Authors:
FORD H
SIDDIQUI MA
DRISCOLL JS
MARQUEZ VE
KELLEY JA
MITSUYA H
SHIRASAKA T
Citation: H. Ford et al., LIPOPHILIC, ACID-STABLE, ADENOSINE DEAMINASE-ACTIVATED ANTI-HIV PRODRUGS FOR CENTRAL-NERVOUS-SYSTEM DELIVERY .2. 6-HALO AND 6-ALKOXY PRODRUGS OF 2'-BETA-FLUORO-2',3'-DIDEOXYINOSINE, Journal of medicinal chemistry, 38(7), 1995, pp. 1189-1195
Authors:
XU ZQ
QIU YL
CHOKEKIJCHAI S
MITSUYA H
ZEMLICKA J
Citation: Zq. Xu et al., UNSATURATED ACYCLIC ANALOGS OF 2'-DEOXYADENOSINE AND THYMIDINE CONTAINING FLUORINE - SYNTHESIS AND BIOLOGICAL-ACTIVITY, Journal of medicinal chemistry, 38(6), 1995, pp. 875-882